Reformation IPO filing tests broader 2026 new-issue demand

Reformation filed for a U.S. initial public offering on Thursday after reporting $507.1 million in 2025 net revenue and first-quarter 2026 sales of $112.3 million, up 30.4 per cent from a year earlier. The sustainable womenswear retailer said in its Form S-1 that it plans to list on the New York Stock Exchange under REF.

The filing gives bankers a cleaner test of the U.S. new-issues market than another AI or defence deal would. Reformation is a recognizable consumer name, not a compute-infrastructure play, and its debut would show how far risk appetite has moved outside the sectors that have dominated 2026 issuance.

That contrast has mattered in recent capital-markets commentary. In a Bloomberg Television interview, Goldman Sachs president and chief operating officer John Waldron said markets were willing to finance “extraordinary companies” tied to the AI build-out.

“Capital markets are demonstrating a willingness to finance these extraordinary companies as we build out this AI infrastructure”
John Waldron, Goldman Sachs president and chief operating officer, Bloomberg Television

Reformation turns that argument into a consumer-market question.

The S-1 showed that about 90 per cent of 2025 sales came from direct-to-consumer channels. Reformation said it had 1,140,000 active customers as of March 28, and first-quarter gross margin reached 70.3 per cent. The company was profitable in 2025, according to the filing, a sturdier operating profile than many growth issuers brought to market in the last cycle.

Those numbers need some qualification. Reformation said the first quarter benefited from tariff refunds, so part of the margin gain may not repeat.

Its heavy direct-to-consumer mix can also flatter profitability compared with wholesale-heavy apparel peers, although it gives management more control over pricing and inventory. For IPO buyers, the core question is whether repeat purchasing and brand retention deserve a public-market multiple closer to high-growth retail than to ordinary apparel.

What the filing says about the IPO window

Bankers have already been making the case that issuance is broadening. CNBC reported this month that executives and advisers were seeing the biotech IPO window reopen after years of subdued activity. MarketWatch pointed to Deutsche Bank data suggesting large offerings do not necessarily derail the wider stock market.

Reformation adds a different sort of test: a consumer brand with household recognition, but without the scarcity story attached to frontier AI names.

Permira will be central to how the market reads the deal. A successful float would offer the buyout firm a liquidity path and could nudge more sponsor-backed consumer companies toward the market if price discovery holds up.

The filing did not include terms, valuation or a share count, so the transaction is not yet a verdict on that pipeline. It does move the question from theory to execution.

For public investors, the stronger signal may sit in customer behaviour rather than branding. Reformation’s 1.14 million active customers and 90 per cent direct-to-consumer revenue share suggest the pitch is less about fashion-cycle momentum than repeat demand at scale.

That distinction matters in IPO marketing because buyers can underwrite a customer base more readily than a short-lived trend. A high gross margin and rising quarterly sales help, but investors will still want to know how much of the recent improvement came from mix, pricing power and temporary tariff-related support.

Until Reformation publishes a range, the filing is more useful as a market signal than as a valuation call. If it can move from filing to pricing without a steep discount, the U.S. IPO market will look open beyond the sectors that have so far pulled in most risk capital. If it stumbles, bankers may decide the window is open only selectively.